CELGENE CORP /DE/

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 47% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
CELGENE CORP /DE/'s trades of Acceleron Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
222.20
Quantity 79,663 +30.3%
Value US$3,897,085
Transaction date
Purchase
Price
401.83
Quantity 9,048 -45.4%
Value US$1,329,832
Transaction date
Purchase
Price
496.34
Quantity 56,481 -13.7%
Value US$220,540
Transaction date
Purchase
Price
43.00
Quantity 706,206 +11.5%
Value US$30,366,858
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-07-13 2020-07-09
S Sale
79,663 +30.3%
222.20
US$3,897,085 		79,663 +30.3% 222.20 US$3,897,085
2020-07-06 2020-07-01
B Purchase
9,048 -45.4%
401.83
US$1,329,832 		9,048 -45.4% 401.83 US$1,329,832
2019-11-14 2019-11-12
B Purchase
56,481 -13.7%
496.34
US$220,540 		56,481 -13.7% 496.34 US$220,540
2019-01-22 2019-01-18
B Purchase
706,206 +11.5%
43.00
US$30,366,858 		706,206 +11.5% 43.00 US$30,366,858